Johnson & Johnson Single-Dose Vaccine Approved for Use in Canada

Pfizer to accelerate delivery of its vaccines over the next few months

A case of test tubes on a lab table during COVID-19 vaccine research at Johnson & Johnson subsidiary Janssen Pharmaceutical in Beerse, Belgium, on June 17, 2020. Virginia Mayo/AP Photo

Health Canada has authorized use of a COVID-19 vaccine made by Johnson & Johnson, making it the first single-dose vaccine to receive approval for use in Canada.

The vaccine, produced by Johnson & Johnson subsidiary Janssen Pharmaceutical, can be stored at regular refrigerated temperatures at 2 to 8 degrees Celsius for at least three months, making it easy to distribute to the provinces and territories.